Kingyork Group Limited (UK Company Number 13477624) operates as an international pharmaceutical contract manufacturer with strategically partnered GMP-certified production facilities across China and India. We hold official manufacturing licenses and quality certifications from multiple factories specializing in injectable medications. Our product portfolio includes over 190 generic medicines, with particular expertise in vitamin injections like B1 (100mg/2ml), B12 (0.5mg/1ml), and therapeutic formulations such as Dexamethasone Sodium Phosphate. Through our registered branches in Germany and Switzerland, we provide European packaging solutions with German addresses and trademark protection, offering African importers EU-compliant documentation and enhanced market credibility.
Our registered German trademark enables us to supply medicines in official EU packaging bearing our Germany branch address, significantly simplifying import processes for African clients. All manufacturing occurs in our licensed partner facilities in China and India, where we implement rigorous British quality standards. This unique model combines cost-effective Asian production with European regulatory advantages. We provide complete documentation packages including factory licenses, EU trademark certificates, and batch-specific quality reports. The system is designed specifically to help African healthcare providers access affordable, quality medicines with verifiable EU connections.
Kingyork maintains contractual partnerships with multiple GMP-certified factories across China and India specializing in sterile injectables. Our manufacturing network includes facilities dedicated to vitamin formulations (B-Complex 2ml, Tri-B injections), anti-inflammatories (Dexamethasone 4mg/1ml), and analgesics (Diclofenac Sodium 75mg/3ml). Each facility undergoes our stringent qualification process and regular quality audits. This distributed production model ensures supply chain resilience while maintaining competitive pricing crucial for African markets. We control the entire process from API sourcing to finished product release, with German packaging adding EU compliance for export markets.
Our product range covers essential therapeutic categories: Vitamin B1 (100mg/2ml) for metabolic support, B12 (0.5mg/1ml) for anemia treatment, and combination products like Tri-B injections. The portfolio includes emergency medications (Dexamethasone 8mg/2ml), gastrointestinal treatments (Metoclopramide 10mg/2ml), and Vitamin K1 (10mg/1ml) for coagulation disorders. All products are manufactured in our licensed Asian facilities under pharmaceutical standards that meet or exceed EU GMP requirements. The German packaging option includes multilingual labeling suitable for diverse African healthcare systems.
Kingyork implements a comprehensive quality control system spanning Asia, Europe, and Africa. Each batch undergoes testing at the production facility (China/India), verification at our UK quality center, and final release from our German hub. Our documentation includes certificates of analysis from both the manufacturing site and EU office. For tropical markets, we provide special stability-tested versions of heat-sensitive products like Vitamin C injections. The system combines Asian production efficiency with European quality expectations at price points accessible to African healthcare providers.
We're establishing direct partnerships with African distributors, hospitals, and NGOs to improve medicine access. Our German packaging and trademark help overcome regulatory barriers in target markets. Future plans include expanding our trademark portfolio to France and Austria while developing Africa-specific formulations. The company maintains strategic stock of essential medicines like Vitamin B complexes in Germany for rapid African delivery. This infrastructure supports our mission to deliver WHO-essential medicines to underserved populations without compromising quality.
As a contract manufacturer, Kingyork partners exclusively with WHO-GMP certified facilities in China and India that meet our stringent quality criteria. We maintain full technical agreements and quality contracts with each production partner. Our licensed facilities specialize in different product categories: one site may produce vitamin injections (B1 100mg/2ml, B12 0.5mg/1ml) while another focuses on steroids (Dexamethasone 4mg/1ml) or analgesics (Diclofenac 75mg/3ml). This specialization ensures optimal expertise for each medicine type. All sites undergo regular audits by our UK-based quality team to maintain consistent standards across the network.
We provide comprehensive documentation packages with every shipment, including manufacturing licenses, GMP certificates, and product-specific dossiers. Our German trademark registration adds an additional layer of authenticity verification for African importers. Batch documentation traces each product to its specific production facility in China or India, with corresponding quality control records. The system is designed to meet the strictest import requirements while maintaining transparency about our global manufacturing model. Clients can request additional documentation like stability studies or method validation reports as needed.
Leveraging our Asian manufacturing network, we offer customized solutions for African markets, including special pack sizes (e.g., 50-vial boxes) or combination products tailored to local treatment protocols. Our facilities can develop heat-stable versions of sensitive medications like Vitamin B complexes for tropical climates. We're currently developing several Africa-specific formulations in response to partner requests, including combination therapies that reduce treatment costs. This flexibility is a key advantage of our contract manufacturing model compared to traditional pharmaceutical producers.
Kingyork maintains buffer stocks of key products like Metoclopramide 10mg/2ml at our German hub for rapid response to African orders. Our logistics network includes temperature-controlled shipping options for sensitive products. For large African orders, we can arrange direct shipments from Asian factories with German documentation to reduce costs. The system provides multiple procurement options to suit different African market needs, from small clinic orders to national tenders, all backed by our EU trademark and quality guarantees.
We're currently qualifying additional manufacturing partners in India to expand our production capacity by 40% in 2024. New facilities will allow us to introduce additional products to our catalog while maintaining our quality standards. Parallel efforts include registering our trademark in more EU countries to strengthen our European credentials. These expansions will further enhance our ability to serve African markets with affordable, quality medicines through our unique EU-Asia-Africa supply model.
Kingyork Group offers a comprehensive selection of injectable vitamins and essential medicines with flexible minimum order quantities to meet diverse market needs. Our flagship vitamin injection line includes Vitamin B1 (100mg/2ml ampoules), Vitamin B12 (0.5mg/1ml ampoules), and combination formulas like Tri-B injections (B1+B2+B12). For therapeutic applications, we provide Dexamethasone Sodium Phosphate (4mg/1ml and 8mg/2ml vials) and Diclofenac Sodium (75mg/3ml ampoules). We accommodate bulk orders with standard MOQs of 300,000 ampoules (packed 10/box), 50,000 vials (10 vials/box), 30,000 tablet boxes, and 30,000 capsule boxes, while remaining flexible to adjust packaging configurations per client specifications. All injectables are produced in sterile, GMP-certified facilities with batch-controlled temperature stability. Our production capacity allows for customized vitamin formulations, including specialized B-complex combinations for different therapeutic applications. The MOQ structure enables cost-efficient procurement for government health programs, hospital networks, and large distributors while maintaining our commitment to quality across all product categories. We provide complete documentation including certificates of analysis, stability studies, and manufacturing compliance reports with every shipment.
Our sterile Paracetamol 300mg/2ml injection provides fast-acting pain relief and fever reduction. Ideal for postoperative care and acute conditions, each ampoule delivers precise dosing with rapid onset. Manufactured in GMP-certified facilities, this formulation ensures optimal bioavailability for effective symptomatic treatment in clinical settings.
This 300mg formulation is particularly suitable for pediatric and adult patients requiring moderate analgesia. The injection offers excellent solubility and stability, with minimal side effects. Properly indicated for headaches, dental pain, and post-immunization pyrexia when oral administration isn't feasible.
The 600mg/4ml concentration provides enhanced analgesia for severe pain cases. This hospital-grade formulation delivers potent antipyretic and analgesic effects, suitable for trauma care and chronic pain management. Each vial undergoes rigorous quality testing for purity and sterility assurance.
With double the potency of standard formulations, our 600mg injection reduces dosing frequency in critical care. Ideal for IV administration in emergency departments and surgical recovery units. The higher concentration maintains efficacy while minimizing fluid load in sensitive patients.
Our Dexamethasone 6.6mg/1ml injection provides potent anti-inflammatory action for allergic disorders and rheumatic conditions. The formulation offers precise dosing for IM or IV administration, with rapid onset of therapeutic effects. Manufactured under strict GMP standards for reliable clinical performance in emergency and chronic care.
The 6.6mg concentration is ideal for specific therapeutic protocols requiring intermediate steroid dosing. Commonly used in asthma exacerbations, cerebral edema, and certain autoimmune conditions. Each vial undergoes rigorous particulate matter testing for patient safety.
This 8mg/2ml dexamethasone injection delivers maximum anti-inflammatory effects for critical care situations. The higher concentration reduces fluid load while maintaining efficacy in treating severe allergic reactions and shock. Preferred in ICU settings for its reliable immunosuppressive action.
Formulated for cases requiring aggressive immunosuppression including COVID-19 protocols and transplant rejection. The 8mg strength allows for less frequent dosing while maintaining therapeutic levels. Suitable for IV push or infusion with proper dilution.
Our Adrenalin 1mg/ml (1:1000) injection is the first-line treatment for severe allergic reactions. Each 1ml ampoule delivers rapid vasoconstriction and bronchodilation during anaphylactic emergencies. Precisely dosed for IM administration with fast absorption to counteract life-threatening symptoms immediately.
Essential for emergency kits and healthcare facilities treating acute hypersensitivity reactions. The 1:1000 concentration is ideal for intramuscular use in adults and children. Manufactured under strict sterile conditions with guaranteed stability for critical situations.
The 0.1mg/ml (1:10,000) Adrenalin formulation is specially designed for IV/IO administration during cardiac arrest. This diluted concentration allows precise titration in ACLS protocols. Each vial provides the critical vasopressor support needed during CPR and severe shock cases.
Used in hospital crash carts and emergency departments for pulseless VT/VF and PEA. The 1:10,000 concentration minimizes arrhythmia risk while maintaining therapeutic effects. Includes color-coded labeling for rapid identification during code situations.